| Financial Year |
March 31 2023 |
| Monetary Funds |
2,305,531,103.61 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
550,500,273.71 |
| Advances to Suppliers |
46,025,052.97 |
| Other Receivables |
7,827,073.42 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,061,112,925.03 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
30,749,328.95 |
| Total Current Assets |
4,027,776,667.20 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
180,395,367.94 |
| Investment Properties |
7,529,043.85 |
| Fixed Assetes |
2,555,808,569.43 |
| Under-construction Projects |
461,881,730.05 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
547,586,921.73 |
| R&D expenses |
-- |
| Goodwill |
711,005,555.09 |
| Long-Term Deferred and Prepaid Expenses |
2,073,200.95 |
| Deferred Income Tax Assets |
54,794,017.93 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
5,031,020,806.13 |
| Total Assets |
9,058,797,473.33 |
| Short-Term Loans |
1,521,968,237.70 |
| Trading Financial liabilities |
16,307,513.56 |
| Notes Payable |
297,509,400.70 |
| Accounts Payable |
772,719,473.55 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
56,258,070.62 |
| Taxes Payable |
18,063,405.72 |
| Interest Payable |
-- |
| Dividend Payable |
2,051,370.43 |
| Other payables |
28,942,853.51 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,841,311.26 |
| Other Current Liabilities |
1,049,404.46 |
| Sub-Total of Current Liabilities |
2,729,425,923.65 |
| Long-term Loans |
10,137,500.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,333,333.00 |
| Deferred Income Tax Liabilities |
105,345,337.92 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
182,607,805.96 |
| Total Liabilities |
2,912,033,729.61 |
| Paid-In Capital(Or Share Stock) |
1,618,715,253.00 |
| Capital Surplus |
2,906,279,032.74 |
| Surplus Reserve |
250,780,507.05 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,371,719,598.21 |
| Minority Stockholder's Interest |
-3,316,844.12 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,150,080,587.84 |
| Owner's Equity（Stockholder's Equity） |
6,146,763,743.72 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,058,797,473.33 |
